The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there are certain people who don't do so well with vaccines and that's the elderly they don't make such robust immune responses and in fact it's this population that you might vaccinate with these new vaccines against coronavirus but they may not make such robust responses so using a monoclonal antibody I think or a combination of monoclonal antibodies would be the way to go in this population
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.